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Abstract
Background: Foot-and-mouth disease (FMD) is a highly contagious viral disease of even-toed ungulates.
Serological diagnosis/surveillance of FMD presents several problems as there are seven serotypes worldwide and
in the event of vaccination it may be necessary to be able to identify FMD infected/exposed animals irrespective
of their vaccination status. The recent development of non-structural 3ABC protein (NSP) ELISA tests has greatly
advanced sero-diagnosis/surveillance as these tests detect exposure to live virus for any of the seven serotypes
of FMD, even in vaccinated populations. This paper analyses the performance of three NSP tests using a Bayesian
formulation of the Hui-Walter latent class model to estimate test sensitivity and specificity in the absence of a
"gold-standard" test, using sera from a well described cattle population in Cameroon with endemic FMD.
Results: The analysis found a high sensitivity and specificity for both the Danish C-ELISA and the World
Organisation for Animal Health (O.I.E.) recommended South American I-ELISA. However, the commercial
CHEKIT kit, though having high specificity, has very low sensitivity. The results of the study suggests that for NSP
ELISAs, latent class models are a useful alternative to the traditional approach of evaluating diagnostic tests against
a known "gold-standard" test as imperfections in the "gold-standard" may give biased test characteristics.
Conclusion: This study demonstrates that when applied to naturally infected zebu cattle managed under
extensive rangeland conditions, the FMD ELISAs may not give the same parameter estimates as those generated
from experimental studies. The Bayesian approach allows for full posterior probabilities and capture of the
uncertainty in the estimates. The implications of an imperfect specificity are important for the design and
interpretation of sero-surveillance data and may result in excessive numbers of false positives in low prevalence
situations unless a follow-up confirmatory test such as the enzyme linked immunoelectrotransfer blot (EITB) is
used.
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Foot-and-mouth disease (FMD) is a highly contagious
viral disease of even-toed ungulates caused by Foot-and-
mouth disease virus (FMDV), which is a member of the
genus Aphthovirus and the family Picornviridae [1]. A
number of non-structural protein (NSP) immunoassays,
designed to detect aphthovirus-specific antibodies to rep-
licating virus in animals irrespective of vaccination status
or for screening multiple-serotype infected/exposed ani-
mals, have been under development in recent years [2-9].
The OIE Reference Laboratory for the Americas, PANAF-
TOSA/PAHO/WHO, has developed and validated a sur-
veillance tool, to accompany the progress of eradication
campaigns in South America, based on a screening NSP
ELISA (the I-ELISA 3ABC), followed by an enzyme linked
immunoelectotransfer blot test (EITB) to clear up false
positive reactions [10]. Because vaccination prevents clin-
ical disease but does not necessarily prevent infection or
persistence [11-13], it is useful to be able to identify ani-
mals which are infected or have been exposed to live virus
irrespective of their vaccination status. The NSP tests offer
an alternative to the virus neutralization test (VNT) [14]
and liquid phase blocking ELISA (LPBE) [15-17]. The VNT
and LPBE detect antibodies to FMDV structural proteins
and require separate testing for each of the seven serotypes
of FMDV and for some subtypes. These tests are time con-
suming to perform, require virus containment facilities
and cannot differentiate vaccinated from convalescing
animals [18]. Furthermore the VNT may not be an appro-
priate comparison for NSP ELISAs since antibodies to the
structural proteins are detected slightly sooner and for
longer than NSP antibodies [19].
The need for a mass screening test for use in vaccinated
populations to detect circulating infection gained impetus
in Europe with the outbreak of FMD in the UK in 2001.
The mass slaughter of millions of sheep and cattle caused
public outrage and has added a political element to the
arguments that vaccination should be used in future FMD
outbreaks. The United Kingdom came close to vaccinating
dairy herds in Cumbria prior to turn-out of cattle in the
spring of 2001 but eventually opted not to amid fears of
prolonging trade bans and consumer resistance to drink-
ing milk from vaccinated cattle [20]. EU regulations have
since been modified to allow for the emergency use of vac-
cination (EU Council Directive 85/511/EEC). The World
Organization for Animal Health (O.I.E.) trade regulations
at the time required 12 months of disease freedom follow-
ing the end of emergency vaccination before a country
could be declared free. However, in 2004 the regulations
were altered and countries can now regain 'FMD free' sta-
tus six months after the end of vaccination providing they
have carried out surveillance with an NSP test (Article
2.2.10.7, O.I.E. Terrestrial Animal Health Code, 2004).
This is three months later than could be achieved follow-
ing a slaughter policy without vaccination.
In order to design and implement an effective vaccination
program and subsequent sero-surveillance, it is necessary
to know the properties of the test(s) intended to be used.
The properties of a diagnostic test are often described
using the sensitivity (Se), i.e. the proportion of true posi-
tives that the test identifies and the specificity (Sp), i.e. the
proportion of true negatives that the test identifies. When
available, these parameters are estimated using animals
with known infectious status. For NSP tests the values
have been obtained using controlled experimental and
field models [8,10,21-23]. Alternatively, studies can be
carried out to compare the diagnostic sensitivity and spe-
cificity of an assay against a standard of comparison i.e. a
"gold standard" test.
Previously some of the authors compared two FMD 3ABC
ELISAs using the VNT as the "gold-standard" [24], i.e. it
was assumed that the Se and Sp of the VNT were both
100%. However, there might be reasons to question the
justification of using the VNT as a "gold-standard". It
appears, that reliable estimates of the duration of the dif-
ferent antibody responses in cattle are lacking. Thus, there
might be justification in disregarding the VNT and com-
pare the NSP tests to each other without assuming that the
true status of the animal is known (i.e. the disease status
is latent). The latent class approach does not assume any
of the tests is a "gold standard" [25-27]. This paper fol-
lows on from our previous evaluation of two NSP tests
using a conventional approach with the VNT as a "gold-
standard" [24].
The objective of the current study was to estimate sensitiv-
ity and specificity of two previously studied NSP tests, the
CHEKIT-FMD-3ABC bo-ov (CHEKIT) ELISA (Bommeli
Diagnostics/Intervet) and the 3ABC blocking ELISA (C-
ELISA) developed in Denmark, as well as the O.I.E. index
NSP test, the I-ELISA 3ABC developed by PANAFTOSA
[10] without assuming that a 'gold standard' was availa-
ble. The test properties were estimated for each of the
three tests in a cattle population from Cameroon where
serotypes O, A and SAT2 were known to be circulating and
where at the time of the original study in 2000, there was
no vaccination [28,29]. The analysis used a Bayesian for-
mulation of the Hui-Walter latent class model for test
evaluation in the absence of a "gold-standard" [26]. Since
this work was carried out the CHEKIT-FMD-3ABC bo-ov
has been reformulated as a mark II kit and the Danish C-
ELISA has been reformulated as a commercial kit and mar-
keted under the name Ceditest® FMDV-NS (Cedi Diagnos-
tics B.V.).Page 2 of 10
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Based on the data given in Table 1, the Se and Sp of the
three tests were estimated using the full set of adult and
juvenile animals in the five administrative Divisions (sub-
populations). To facilitate the discussion of the underly-
ing assumptions of the latent class model, the test
parameters were estimated both by combining all three
tests and then by using only two tests at a time. The results
of the analysis on the full data set are given in Table 3. The
parameter estimates based on the data from all three tests
gives high posterior mean estimates for the Se for both the
C-ELISA (96.9%) and the I-ELISA (97.1%) but a very low
posterior mean estimate for the CHEKIT (33.2%). Con-
versely, the posterior mean Sp is very high for the CHEKIT
(99.0%) but lower for both of the other tests (90.9% and
88.8% respectively). However the posterior 95% credibil-
ity interval (PCI) appear to overlap and there is little evi-
dence of a significant shift in the estimates though the PCI
are wider.
The results for the sub-set of juvenile animals (8–24
months old) which use the data from Table 2 are given in
Table 4. Based on this smaller data set and using the three
tests combined, the CHEKIT posterior mean estimate
shows a small change with a slight reduction in the Se
(26.1%). The C-ELISA also has a lower Se posterior mean
estimate (92.6%) but the Sp is conversely slightly higher
(96.1%). A similar shift is seen with the I-ELISA (92.3%
and 93.7% respectively).
The key issue in traditional test parameter estimation is
the availability of a "gold-standard" test, i.e. a test whose
outcome can be directly interpreted as presence or
absence of disease/infection. Quite often however, the
need for such a test seems to determine the definition of
the disease and this may introduce selection bias in the
test evaluation [30] or force a disease definition, which
does not necessarily reflect the essential properties of the
disease, but merely the detectable properties. The esti-
mates for the relative Se and Sp of the C-ELISA test when
compared to the VNT as a "gold standard" for this cattle
population were 71% and 90% respectively [24]. The new
best estimate of 96.9% for the Se of the C-ELISA is much
higher, although the estimate for the Sp did not change
(90.0%). This difference is likely to reflect the problem of
defining what a seropositive animal means. Using the
VNT as a "gold standard" results in animals exposed to
FMD virus up to several years previously [22,31-33], being
classified as seropositive due to the long half-life on neu-
tralising antibodies [32]. By contrast, NSP antibodies do
not appear to persist for more than 6–12 months [6,22]
though there seems to be much variation in these esti-
mates [34] and so a different set of animals will be classi-
fied as seropositive by an NSP test. This difference in test
classification using a poor "gold-standard" could result in
the comparative test (in this situation the NSP test)
appearing to perform poorly. However, from a disease
control and a decision maker's point of view, what is
important is evidence of recent exposure to an FMD virus
or continuing sub-clinical disease post-vaccination which
the NSP tests are directed at.
Using a latent class analysis circumvents the need for an
available "gold-standard" test hence providing an alterna-
tive to the classical analyses where the problems with
selection bias or improper disease definitions. However,
there are explicit and implicit assumptions of the latent
class analysis, which require that the results of the analysis
are scrutinized. Specifically, there is a need to explore the
definition of the disease imposed by applying a set of
tests. Essentially the definition of disease in a latent class
analysis can be perceived as whatever the tests agreed
upon. The impact of this is that the definition of disease
might depend on the subset of tests used in the analysis.
This is very clearly illustrated in Toft et al. [35], where the
choice of tests in the latent class analysis dramatically
changes the properties of the tests, due to a changed per-
ception of what constitutes a "diseased" individual. The
problem is, essentially, that a test result rarely is a direct
measure of what we are looking for in the test subject. An
example is the use of antibody tests which may detect past
exposure rather than current infection with the agent.
In order to explore how the choice of tests might impact
the definition of disease in this cattle population, we did
a pair-wise comparison of the 3ABC ELISA tests to com-
Table 1: Cross-tabulated results for the CHEKIT, C-ELISA and I-ELISA NSP tests.
Test combination (Chekit CELISA I-ELISA)
Province +/+/+ +/+/- +/-/+ +/-/- -/+/+ -/+/- -/-/+ -/-/- Total (n)
Vina 78 4 1 3 166 23 26 173 474
Mbere 44 0 2 1 54 18 8 96 223
Djerem 24 0 1 0 52 11 20 145 253
Mayo Banyo 31 0 2 1 103 9 24 105 275
Faro et Deo 29 1 0 0 42 9 7 62 150
Cross-tabulated results for the CHEKIT, C-ELISA and I-ELISA NSP tests in the full population stratified by the five administrative Divisions in the 
Adamawa Province of Cameroon (n = 1,375).Page 3 of 10
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lences when using all three tests opposed to any
combination of just two tests (Tables 3). Given the uncer-
tainty associated with the estimates, there are no discern-
able differences between the estimates of Se, Sp and
prevalence across the combinations of test. This leads us
to conclude that the disease definition remains the same
regardless of which tests are used for the analysis.
However, for the juvenile sub data set (Table 4), there
seems to be some inconsistency between estimates when
doing pair-wise comparisons, most noticeably in the esti-
mate of the Se of the CHEKIT ELISA. Comparing the sce-
nario with all three tests to the C-ELISA verses the I-ELISA
there are no relevant differences, but when either of these
two tests are evaluated alone against the CHEKIT ELISA
the estimates seem to shift towards something that indi-
cates a changed perception of what constitutes a "dis-
eased" case. However, it is the author's experience that this
shift might also be explained by the combination of the
poor Se of the CHEKIT ELISA and the relatively small sam-
ple size.
The assumption of conditional independence between
the tests given disease status is vital to the presented anal-
ysis. The disease status defined by three NSP ELISAs for
FMD virus must be considered a measure of the presence
of NSP antibodies. Conditional on such a 'disease status'
there is no reason to assume that the three tests are not
conditionally independent. It is possible to assess pair-
wise conditional dependence, i.e. assuming that one tests
is conditionally independent given disease status of the
other two potentially dependent tests. However, a model
assuming that all three tests are conditional dependent
given disease status is unidentifiable and can as such not
be evaluated without specifying informative priors. Fur-
thermore, it would not make sense to assume such a cor-
relation structure as it would merely imply that none of
the tests were measuring what we are looking for. For
completeness, we compared the three models allowing for
pair-wise conditional dependence to the model assuming
conditional independence between tests given disease sta-
tus using the Deviance Information Criteria (DIC) [36].
The DIC did not suggest that any of the models allowing
conditional dependence between two tests given disease
status were to be preferred over the model assuming con-
ditional independence between the three tests given dis-
ease status.
The prevalence estimates from this analysis follow a simi-
lar pattern across the five Divisions to the herdsmen
reported outbreaks for the 12 months prior to the inter-
Table 3: Latent class estimates (posterior mean and 95% credibility intervals (PCI)) of test Se and Sp and Divisional seroprevalence for 
the full data set (adults and juveniles) using all three tests and pairs of tests in combination
All three tests I-ELISA+C-ELISA I-ELISA+CHEKIT CHEKIT+C-ELISA
Parameter Mean 95% PCI Mean 95% PCI Mean 95% PCI mean 95% PCI
SeCHEKIT 33.2 (29.6; 37.0) - - 34.2 (28.0; 45.1) 36.0 (29.1; 47.0)
SpCHEKIT 99.0 (98.1; 99.1) - - 99.3 (98.0; 100.0) 99.1 (97.7; 100.0)
SeC-ELISA 96.9 (94.0; 99.1) 95.0 (88.2; 99.7) - - 96.6 (92.7; 99.8)
SpC-ELISA 90.9 (87.9; 93.8) 94.9 (88.9; 99.7) - - 86.4 (72.3; 98.8)
SeI-ELISA 97.1 (94.4; 99.1) 93.3 (88.5; 99.1) 96.4 (92.7; 99.6) - -
SpI-ELISA 88.8 (85.8; 92.0) 90.8 (85.6; 97.9) 88.2 (72.3; 99.3) - -
pvina 54.1 (49.1; 59.1) 57.4 (51.1; 63.6) 53.5 (41.1; 61.8) 51.7 (39.5; 60.7)
pmbere 46.3 (39.4; 53.3) 50.2 (41.5; 58.5) 44.5 (33.7; 53.5) 47.2 (35.5; 57.1)
pdjerem 30.1 (25.1; 37.0) 34.0 (26.7; 42.1) 30.9 (17.8; 41.8) 25.8 (14.5; 37.0)
pbanyo 50.9 (44.5; 57.2) 54.3 (46.6; 62.5) 52.5 (36.6; 62.8) 44.5 (29.3; 56.2)
pfaro 49.4 (41.4; 57.5) 53.0 (43.5; 61.8) 48.0 (35.2; 58.9) 48.4 (35.7; 59.9)
Table 2: Cross-tabulated results for the CHEKIT, C-ELISA and I-ELISA NSP tests.
Test combination (Chekit C-ELISA I-ELISA)
Province +/+/+ +/+/- +/-/+ +/-/- -/+/+ -/+/- -/-/+ -/-/- Total (n)
Vina 20 3 1 1 51 10 15 128 229
Mbere 3 0 0 1 19 9 4 64 100
Djerem 8 0 0 0 10 1 7 84 110
Mayo Banyo 3 0 2 1 33 5 8 83 135
Faro et Deo 11 0 0 0 15 2 1 46 75
Cross-tabulated results for the CHEKIT, C-ELISA and I-ELISA NSP tests in the sub data set of juvenile (8–24 month old) animals, stratified by the 
five administrative Divisions in the Adamawa Province of Cameroon (n = 649).Page 4 of 10
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reported estimates were 77%, 57%, 37%, 44% and 73%
for the Vina, Mbere, Djerem, Mayo Banyo and Faro et Deo
Divisions respectively [37,38]. The model assumes that
the tests perform the same in all the sub-populations (i.e.
Divisions) and that only the true prevalence differs. These
Divisions were the obvious way to divide the population
but others could have been used. The effects of using dif-
ferent ways to divide the population were not explored.
The prevalence estimates based on the juveniles only were
significantly lower than for the full population sample.
This would be expected since only relatively recent expo-
sure is captured in this subpopulation.
The estimates of Se and Sp for the NSP tests presented here
are lower than those obtained from experimental and
field models in South American livestock populations for
the I-ELISA [9,10,21] as well as for the C-ELISA and
CHEKIT tests (unpublished results). Studies using sera
panels from FAO have also suggested very high parameter
estimates of 98% Se and 99.7% Sp in non-vaccinated cat-
tle for the Ceditest® (C-ELISA) and 98% Se and 97.2% Sp
for the CHEKIT ELISA [39]. Estimates for the C-ELISA give
similar ranges of specificity of 95.1% before and 99.4%
after heat inactivation in naïve cattle though these drop
slightly to 85.3 and 95.7 in vaccinated cattle [40]. A more
recent intensive validation exercise has produced esti-
mates of Sp of 97.3% for the I-ELISA, 98.2% for CHEKIT
and 97.2% for the Ceditest (the C-ELISA). These are
higher than the estimates from this study with the excep-
tion of the CHEKIT test [41]. Estimates of diagnostic Se
varied with time since infection but were 100% for the I-
ELISA more than 100 days post infection compared to the
50% for both the CHEKIT and Ceditest [41]. It is clear
from this that the estimates of diagnostic Se depends in
part on the time from infection/exposure, the mix of ani-
mals sampled and their exposure history. These popula-
tion specific factors will influence the performance of
these test when applied to real populations in the field
compared to panels of experimentally derived sera and
may in part explain some of the variation in estimates
being reported. It is not clear how significant these differ-
ences are in practical terms. In addition, it is also impor-
tant to remember that test parameters are population
specific and it is a well recognized problem that diagnostic
test can have specificity problems when applied in an Afri-
can context [42].
Conclusion
The use of latent class models for the evaluation of diag-
nostic tests in the absence of a "gold-standard" test consti-
tute a useful alternative or addition to the classic analysis
for evaluation of tests, such as antibody tests for FMD.
This work has also highlighted the problem of defining
"disease" on the basis of serological tests, particularly
when serological results have to be interpreted without
additional epidemiological information. It also suggests
that the C-ELISA and I-ELISA are both highly sensitive
tests for use in cattle populations with multiple exposures
to different FMD virus serotypes. However, these NSP tests
all lack specificity and this may create difficulties in
designing sero-surveillance strategies as the number of
herds with false positives may overwhelm the available
resources to deal with them unless a confirmatory test
such as the EITB is also used.
Methods
Study design
The study design has been described previously [37]. In
brief, the study area was the five administrative Divisions
of the 64,000 km2 Adamawa Province of Cameroon (Fig-
ure 1). A sample frame of the cattle herds in the area was
constructed from the rinderpest vaccination lists held by
the local Veterinary Centres. A cross-sectional study
Table 4: Latent class estimates (posterior mean and 95% credibility intervals (PCI)) of test Se and Sp and Divisional seroprevalence for 
the sub-data set (juveniles only) using all three tests and pairs of tests in combination
All three tests I-ELISA+C-ELISA I-ELISA+CHEKIT CHEKIT+C-ELISA
Parameter Mean 95% PCI Mean 95% PCI Mean 95% PCI mean 95% PCI
SeCHEKIT 26.1 (20.1; 32.6) - - 43.2 (22.3; 82.0) 47.7 (22.5; 90.0)
SpCHEKIT 99.1 (97.9; 99.8) - - 99.2 (97.7;100.0) 99.0 (97.5;100.0)
SeC-ELISA 92.6 (84.5; 98.3) 90.4 (80.0; 99.5) - - 93.6 (82.5; 99.8)
SpC-ELISA 96.1 (92.8; 99.4) 97.0 (92.4; 100.0) - - 83.2 (72.9; 98.5)
SeI-ELISA 92.3 (84.9; 98.0) 90.5 (82.7; 99.1) 91.6 (80.6; 99.4) - -
SpI-ELISA 93.7 (90.2; 97.7) 94.9 (90.0; 99.6) 82.4 (72.0; 97.5) - -
pvina 38.2 (31.1; 45.9) 39.8 (31.1; 48.6) 28.3 (12.5; 44.5) 25.8 (11.3; 43.0)
pmbere 26.7 (17.4; 37.9) 29.5 (18.6; 41.2) 11.8 (2.1; 29.1) 14.7 (2.0; 36.6)
pdjerem 21.0 (13.6; 29.4) 22.6 (14.4; 32.0) 16.0 (6.7; 30.3) 12.9 (5.4; 23.6)
pbanyo 31.5 (23.1; 40.7) 32.7 (23.7; 42.6) 17.8 (3.4; 37.9) 13.9 (1.5; 35.6)
pfaro 36.6 (26.0; 48.0) 37.6 (26.7; 49.2) 28.1 (13.8; 27.8) 28.3 (12.9; 46.2)Page 5 of 10
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(by Centre and Herd) random sampling strategy. The pro-
gram 'Survey Toolbox' [43] calculated a two-stage sample
of 54 centres and three herds per centre, allowing for a
10% non-response rate (see Bronsvoort et al. [37] for sam-
ple size calculation). The within herd sample strategy was
based on a limit of detection calculation [44] and
assumed a perfect test and a within herd seroprevalence of
50%. For an average herd of 70 animals with a 95% prob-
ability of finding at least 1 positive animal in the sample,
a sample size of five is needed. Using random number
tables, five juvenile (8–24 month old) and five adult (>24
months old) cattle were cast, examined for lesions and a
serum sample taken from each animal. Blood samples
were centrifuged at 1100 g for 10 minutes in the field
using a 'Mobilespin' 12 V field centrifuge (Vulcon Tech-
nologies) or a hand crank centrifuge (OFI Testing Equip-
ment, Inc.) and approximately 3.5 ml of serum was
aliquoted into 2 × 1.8 ml cryovials (Nunc). The serum was
kept at 4°C in a portable gas fridge until they could be fro-
zen and stored at -20°C. The sera were carried to the UK
on dry ice and stored at -20°C at the FMDV World Refer-
ence Laboratory, Pirbright, UK (WRL). The herds were
presumed to be unvaccinated since no government
licenses have been issued to import vaccines into the
country and no herdsman reported using an FMDV vac-
cine. In addition, it is unlikely private herdsmen would be
vaccinating independently since the vaccine is very expen-
sive. The field study was conducted between April and
October 2000. The diagnostic testing was carried out as
described below and each laboratory tested the samples
blind without knowing any previous test results.
Diagnostic tests
CHEKIT™-3ABC-FMD ELISA
The CHEKIT-ELISA was used according to the manufac-
turer's 2002 instructions. Briefly, the serum was diluted 1/
100 and added in duplicate to the wells of a 96 well
microtitre plate pre-coated with the vector expressed viral
3ABC antigen. Antibodies specific to 3ABC were bound to
the antigen forming an antigen/antibody complex on the
plate surface. Unbound antibody was washed away. A
horseradish peroxidase labeled guinea pig anti-bovine
IgG conjugate was added which bound to any antibody/
antigen complexes. Unbound conjugate was removed by
washing and the chromagen substrate added. The degree
of color that developed was proportional to the amount
of antibody complexed on the plate surface and read at
405 nm with a spectrophotometer. The final reading for
the sample was calculated as follows using the mean of
each pair of samples and the median of the 4 positive and
4 negative control sera supplied with the kit and measured
on each plate:
The manufacturers recommend interpretation was: <20%
is negative, 20–30% is ambiguous and >30% is positive.
These tests were carried out in IAH, Pirbright, UK in 2002.
FMD-3ABC blocking ELISA
The C-ELISA was performed as described previously [23].
Briefly, the original samples from Cameroon were aliq-
uoted and heat treated at 56°C for 2 hours and then
shipped to Denmark for testing. Microtiter plates were
prepared by capturing 3ABC protein produced in the Bac-
ulovirus expression system with a monoclonal antibody
(MabL74D5) coated on the plates. Dilutions (1:5) of the
sera were added and incubated overnight, washed and the
competing antibody, horseradish peroxidase conjugated
MabL74D5 added and incubated for a further hour. The
plates were washed and the chromagen substrate (TMB
H2O2) was added and incubated for 15 minutes at room
temperature at which time the color development was
measured at 450 nm. The results were expressed as a per-
centage of the negative control values from negative sera
supplied with the kits as shown:
The recommended cut-off is ≤ 50% for a positive result.
These tests were carried out in Denmark in 2002.
FMD-PANAFTOSA 3ABC I-ELISA
Aliquots of the heat treated sera were sent to PANAFTOSA
for screening using the I-ELISA. This test has been
described in detail elsewhere [9,45]. Briefly, this is an
indirect ELISA using E.coli expressed purified polyprotein
3ABC coating of the plates. Test or reference sera were
added in 1:20 dilution in blocking buffer (PBS/0.05%
Tween 20/5% non-fat milk/10% equine sera/0.1% E.coli
537 extract) and incubated for 30 minutes at 37°C.
Bound bovine antibodies were detected with rabbit anti-
bovine IgG peroxidise conjugate (Sigma Chemical CO.)
and 3,3',5,5'-tetramethlybenzidine plus 0.004% (w/v)
H2O2 in phosphate-citrate buffer at pH 5.0. The colour
development was stopped after 15 minutes using 2 M
H2SO4 and the OD read at 450 nm. Results were expressed
as percentage positivity referred to a positive control sera.
Percentage positivity values ≥ 10 were considered positive.
Two samples had insufficient sera for completion of the I-
ELISA test, so the final data set was for 1,375 animals.
These tests were carried out at PANAFTOSA, Brazil in
2004.
value
OD OD
OD OD
sample neg
pos neg
% =
−
−
×100
OD
OD
OD
sample
mean negative controls
% = ×
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base and cross tabulated according to whether all tests
were positive (+/+/+), the CHEKIT and C-ELISA were pos-
itive and the I-ELISA negative (+/+/-) etc as shown in
Table 1 for the all animals and in Table 2 for the sub-pop-
ulation of juveniles (8–24 month old).
Statistical analysis
Hui & Walter [26] introduced a latent class approach to
the evaluation of diagnostic tests in absence of a "gold-
standard". The Hui-Walter paradigm for test evaluation in
the absence of a "gold-standard" requires the presence of
two (or more) tests evaluated in two (or more) popula-
tions and furthermore that: the prevalence of the disease
is different within each population; the tests have the
same properties across populations; and the tests must be
conditionally independent given the disease status. Con-
ditional independence given disease status between two
tests implies that if the true status of the test subject is
known, then knowing the outcome (e.g. positive) of one
of the tests will not change our belief in a specific test
result (e.g. positive) of the other test.
In Toft et. al. [46] the original maximum likelihood for-
mulation was compared to a Bayesian model. For sample
sizes such as those in the present study the Bayesian
model is preferable. The Bayesian version of the Hui-Wal-
ter model assumes that for the ith subpopulation the
counts (Oi) of the different combinations of test results,
e.g. +/+/+, +/+/-, +/-/+, etc for three tests, follow a multi-
nomial distribution:
Oi|Sej, Spj, pi ~ Multinominal(Pri, ni) for i = 1,2,..., S and
j = 1,2,..., T
where S is the number of subpopulations and T is the
number of tests and Pri is a vector of probabilities of
observing the individual combinations of test results.
Conditioning on the (latent) disease status, these proba-
bilities can be specified using Se and Sp of the tests and
the prevalence (p) of the subpopulations. As an example,
for three tests the probability of observing all three tests
positive in the ith subpopulation is given as:
Pr(T1+, T2+, T3+) = Pr(T1+, T2+, T3+|D+)Pr(D+) + Pr(T1+,
T2+, T3+|D-)Pr(D-)  Eq.1
= Pr(T1+|D+) Pr(T2+|D+) Pr(T3+|D+)Pr(D+)
+ Pr(T1+|D-) Pr(T2+|D-) Pr(T3+|D-)Pr(D-)  Eq.2
= Se1 Se2 Se3 pi + (1-Sp1) (1-Sp2) (1-Sp3)(1-pi)  Eq.3
where the first transformation (Eq.1) uses conditioning
on the disease status, the second (Eq.2) utilizes the
assumption of conditional independence between tests
given disease status and the third (Eq.3) merely renames
the parameters using more familiar terms. The other seven
probabilities for the three test scenarios may be similarly
derived.
In a Bayesian analysis all parameters are given distribu-
tions. Hence, prior distributions for the test properties
and the prevalence within the subpopulations must be
specified. For this analysis, we did not want to utilize
potential prior information about the tests and preva-
lence, thus we chose to use uninformative priors in the
shape of uniform distributions on the interval between
zero and one, modelled using the Beta(1,1) distribution.
The model was implemented in WinBUGS [47], which is
a general purpose modelling tool which uses Markov
Chain Monte Carlo (MCMC) methods for Bayesian infer-
ence. Put simply, MCMC are a method for sampling from
the posterior distribution of interest (the Markov Chain
element) and subsequently calculating the relevant meas-
ures, e.g. means, medians and standard deviations of the
parameters (the Monte Carlo element). To ensure that the
sample is obtained from the distribution of interest, the
first part of the Markov Chain, the so-called burn-in, is
discarded and the subsequent samples are used for infer-
ence. However, prior to using the samples for inference,
the convergence of the sample chain must be assessed. For
this analysis, the first 5,000 iterations were discarded as a
burn-in and every tenth of the following 50,000 iterations
were kept for posterior inference (the chain was thinned,
to reduce auto-correlation between samples). Conver-
gence of the chain after the initial burn-in was assessed by
visual inspection of the time-series plots for the parame-
ters as well as Gelman-Rubin diagnostic plots using three
sample chains with different starting values [48].
The samples were used for inference by calculating poste-
rior means and posterior 95% credibility intervals (PCI)
for the Se, Sp and p. The PCI is the central 95% of the
probability distribution for a parameter, i.e. endpoints are
the 2.5% and 97.5% percentiles, respectively. There were
no discernible differences between posterior means and
medians; hence the means were reported for purposes of
discussion, while the 95% PCI should be seen as the pri-
mary results.
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